170

Hepatobiliary&Pancreas Surgery
Focuses on the health of liver, bile, and pancreatic organs.
Sub Categories on Hepatobiliary&Pancreas Surgery
Latest Articles
Phytic acid-based nanomedicine shows promise for metabolic dysfunction-associated steatohepatitis therapy

Phytic acid-based nanomedicine shows promise for metabolic dysfunction-associated steatohepatitis therapy

by Higher Education PressCePA exerts a liver-targeted mTOR repressive function, alleviating MASH progression and fat accumulation in high-fat diet-fed mice. Credit: Fenghua Xu, Shoujie Zhao, Yejing Zh

Phytic acid-based nanomedicine shows promise for metabolic dysfunction-associated steatohepatitis therapy

by Higher Education PressCePA exerts a liver-targeted mTOR repressive function, alleviating MASH progression and fat accumulation in high-fat diet-fed mice. Credit: Fenghua Xu, Shoujie Zhao, Yejing Zh
How Liver Cancer Is Diagnosed

How Liver Cancer Is Diagnosed

How Liver Cancer Is DiagnosedA biopsy is often not neededByColleen Doherty, MDUpdated on January 03, 2024Medically reviewed byRobert Burakoff, MDLiver cancer(also called&

How Liver Cancer Is Diagnosed

How Liver Cancer Is DiagnosedA biopsy is often not neededByColleen Doherty, MDUpdated on January 03, 2024Medically reviewed byRobert Burakoff, MDLiver cancer(also called&
Insight on novel genetic approaches to metabolic liver diseases

Insight on novel genetic approaches to metabolic liver diseases

by Wayne State UniversityCredit: CC0 Public DomainDiabetes, obesity and nonalcoholic fatty liver disease (NAFLD) are all common diseases that can lead to serious health implications. NAFLD affect

Insight on novel genetic approaches to metabolic liver diseases

by Wayne State UniversityCredit: CC0 Public DomainDiabetes, obesity and nonalcoholic fatty liver disease (NAFLD) are all common diseases that can lead to serious health implications. NAFLD affect
Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease

Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease

by New York UniversityThe study identified the CNNM4 protein as a key regulator of magnesium (Mg) in the liver and potential therapeutic target for non-alcoholic fatty liver disease (NASH). Credi

Protein controlling magnesium identified as therapeutic target for non-alcoholic fatty liver disease

by New York UniversityThe study identified the CNNM4 protein as a key regulator of magnesium (Mg) in the liver and potential therapeutic target for non-alcoholic fatty liver disease (NASH). Credi
Diabetes and Liver Cancer: What Is the Relationship?

Diabetes and Liver Cancer: What Is the Relationship?

Diabetes and Liver Cancer: What Is the Relationship?ByJames Myhre & Dennis Sifris, MDPublished on November 17, 2022Medically reviewed byIsabel Casimiro, MD, PhDDiabetes&nbs

Diabetes and Liver Cancer: What Is the Relationship?

Diabetes and Liver Cancer: What Is the Relationship?ByJames Myhre & Dennis Sifris, MDPublished on November 17, 2022Medically reviewed byIsabel Casimiro, MD, PhDDiabetes&nbs
Bacteria in the bile duct may provide a new clue for treating liver disease

Bacteria in the bile duct may provide a new clue for treating liver disease

by ElsevierRepresentative flow plots showing CD69+ granzyme B+(GrB+) activated mucosal-associated invariant T (MAIT) cells within peripheral blood mononuclear cells (PBMCs) after incubation with

Bacteria in the bile duct may provide a new clue for treating liver disease

by ElsevierRepresentative flow plots showing CD69+ granzyme B+(GrB+) activated mucosal-associated invariant T (MAIT) cells within peripheral blood mononuclear cells (PBMCs) after incubation with
A drug that lowers blood lipids could treat the world's most common liver disease

A drug that lowers blood lipids could treat the world's most common liver disease

byUniversity of BarcelonaCredit:Biomedicine & Pharmacotherapy(2024). DOI: 10.1016/j.biopha.2024.117067The University of Barcelona has led a study that suggests using the drug kno

A drug that lowers blood lipids could treat the world's most common liver disease

byUniversity of BarcelonaCredit:Biomedicine & Pharmacotherapy(2024). DOI: 10.1016/j.biopha.2024.117067The University of Barcelona has led a study that suggests using the drug kno
An artificial hepatocyte growth factor mimetic ameliorates non-alcoholic steatohepatitis in mouse model

An artificial hepatocyte growth factor mimetic ameliorates non-alcoholic steatohepatitis in mouse model

byKanazawa UniversityCredit:iScience(2024). DOI: 10.1016/j.isci.2024.110426A research group led by Associate Professor Katsuya Sakai, Researcher Nichole Marcela Rojas-Chaverra, and P

An artificial hepatocyte growth factor mimetic ameliorates non-alcoholic steatohepatitis in mouse model

byKanazawa UniversityCredit:iScience(2024). DOI: 10.1016/j.isci.2024.110426A research group led by Associate Professor Katsuya Sakai, Researcher Nichole Marcela Rojas-Chaverra, and P
Fecal transplant trial provides hope for liver disease patients

Fecal transplant trial provides hope for liver disease patients

by King's College LondonCredit: Pixabay/CC0 Public DomainThe UK is to launch a clinical trial of a "poo transplant" that researchers believe could treat advanced liver disease and f

Fecal transplant trial provides hope for liver disease patients

by King's College LondonCredit: Pixabay/CC0 Public DomainThe UK is to launch a clinical trial of a "poo transplant" that researchers believe could treat advanced liver disease and f
Aging exacerbates oxidative stress and liver fibrosis in an animal model of Down Syndrome

Aging exacerbates oxidative stress and liver fibrosis in an animal model of Down Syndrome

by Impact Journals LLCDS mice show a marked increase in fibrotic markers. Credit:Aging(2024). DOI: 10.18632/aging.205970A new research paper titled "Aging exacerbates oxidative stress

Aging exacerbates oxidative stress and liver fibrosis in an animal model of Down Syndrome

by Impact Journals LLCDS mice show a marked increase in fibrotic markers. Credit:Aging(2024). DOI: 10.18632/aging.205970A new research paper titled "Aging exacerbates oxidative stress
Causes and Risk Factors of Liver Disease

Causes and Risk Factors of Liver Disease

Causes and Risk Factors of Liver DiseaseByKelly BurchUpdated on October 17, 2022Medically reviewed byRobert Burakoff, MDYourliveris one of the largest organs in you

Causes and Risk Factors of Liver Disease

Causes and Risk Factors of Liver DiseaseByKelly BurchUpdated on October 17, 2022Medically reviewed byRobert Burakoff, MDYourliveris one of the largest organs in you
Research reveals link between spinal muscular atrophy and liver damage

Research reveals link between spinal muscular atrophy and liver damage

byAgency for Science, Technology and Research (A*STAR), SingaporeGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI173702An international study has

Research reveals link between spinal muscular atrophy and liver damage

byAgency for Science, Technology and Research (A*STAR), SingaporeGraphical abstract. Credit:Journal of Clinical Investigation(2024). DOI: 10.1172/JCI173702An international study has